KR890012940A - 1-(4-아미노페닐)-2-헥사메틸렌이미노프로파논, 이의 제조방법 및 치료적 용도 - Google Patents
1-(4-아미노페닐)-2-헥사메틸렌이미노프로파논, 이의 제조방법 및 치료적 용도 Download PDFInfo
- Publication number
- KR890012940A KR890012940A KR1019890001437A KR890001437A KR890012940A KR 890012940 A KR890012940 A KR 890012940A KR 1019890001437 A KR1019890001437 A KR 1019890001437A KR 890001437 A KR890001437 A KR 890001437A KR 890012940 A KR890012940 A KR 890012940A
- Authority
- KR
- South Korea
- Prior art keywords
- aminophenyl
- hexamethyleneiminopropanone
- addition salts
- acceptable addition
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (8)
1-(4-아미노페닐)-2-헥사메틸렌이미노프로파논 및 약제학적으로 허용되는 이의 부가염중에서 선택된 화합물.
1-(4-아미노페닐)-2-헥사메틸렌이미노프로파논 디하이드로클로라이드.
제1항 또는 2항에 따른 화합물의 유효량 및 치료학적으로 허용되는 부형제를 함유함을 특징으로 하는 치료적 조성물.
우울증 및 우울상태와 관련된 인간의 치료에 사용되는, CNS에 대한 항우울 작용을 갖는 의약적 생성물을 제조하기 위한, 1-(4-아미노페닐)-2-헥사메틸렌이미노프로파논 및 약제학적으로 허용되는 이의 부가염 중에서 선택된 물질의 용도.
면역자극이 필요한 인간의 치료에 사용되는, 면역 자극성 의약적 생성물을 제조하기 위한, 1-(4-아미노페닐)-2-헥사메틸렌이미노프로파논 및 약제학적으로 허용되는 이의 부가염 중에서 선택된 물질의 용도.
산 매질중에서 상응하는 4-아세틸아미노페닐 유도체를 가수분해시킴을 특징으로 하여, 1-(4-아미노페닐)-2-헥사메틸렌이미노프로파논 및 이의 부가염을 제조하는 방법.
1-(4-아미노페닐)-2-헥사메틸렌이미노프로파논 및 약제학적으로 허용되는 이의 부가염중에서 선택된 화합물을 우울증 및 우울상태의 치료를 필요로 하는 인간에게 투여함을 특징으로 하여, 우울증 및 우울상태를 치료하는 방법.
1-(4-아미노페닐)-2-헥사메틸렌이미노프로파논 및 약제학적으로 허용되는 이의 부가염중에서 선택된 화합물을 면역학적 기능의 자극을 필요로 하는 인간에게 투여함을 특징으로 하여, 면역학적 기능을 자극하는 방법.
※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8801565A FR2626881B1 (fr) | 1988-02-10 | 1988-02-10 | 1-(4-aminophenyl)-2-hexamethyleneiminopropanone, procede de preparation et utilisation en therapeutique |
FR8801565 | 1988-02-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR890012940A true KR890012940A (ko) | 1989-09-20 |
Family
ID=9363135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890001437A KR890012940A (ko) | 1988-02-10 | 1989-02-09 | 1-(4-아미노페닐)-2-헥사메틸렌이미노프로파논, 이의 제조방법 및 치료적 용도 |
Country Status (10)
Country | Link |
---|---|
US (1) | US4983599A (ko) |
EP (1) | EP0328460A3 (ko) |
JP (1) | JPH01316369A (ko) |
KR (1) | KR890012940A (ko) |
CN (1) | CN1035290A (ko) |
DK (1) | DK52989A (ko) |
FR (1) | FR2626881B1 (ko) |
IL (1) | IL89186A0 (ko) |
NO (1) | NO890519L (ko) |
PT (1) | PT89666A (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994008964A1 (en) * | 1992-10-16 | 1994-04-28 | Asahi Kasei Kogyo Kabushiki Kaisha | N-phenethylazepine derivative and use thereof |
FR2849029B1 (fr) | 2002-12-20 | 2005-03-18 | Lafon Labor | Procede de preparation et formes cristallines des enantiomeres optiques du modafinil. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2569184A1 (fr) * | 1984-08-20 | 1986-02-21 | Lafon Labor | Derives de 1-(aminophenyl) therapeutique et leur procede de preparation |
-
1988
- 1988-02-10 FR FR8801565A patent/FR2626881B1/fr not_active Expired - Lifetime
-
1989
- 1989-02-03 DK DK052989A patent/DK52989A/da not_active Application Discontinuation
- 1989-02-06 IL IL89186A patent/IL89186A0/xx unknown
- 1989-02-08 NO NO89890519A patent/NO890519L/no unknown
- 1989-02-09 US US07/308,226 patent/US4983599A/en not_active Expired - Fee Related
- 1989-02-09 KR KR1019890001437A patent/KR890012940A/ko not_active Application Discontinuation
- 1989-02-09 PT PT89666A patent/PT89666A/pt not_active Application Discontinuation
- 1989-02-09 JP JP1028797A patent/JPH01316369A/ja active Pending
- 1989-02-10 CN CN89100734A patent/CN1035290A/zh active Pending
- 1989-02-10 EP EP89400385A patent/EP0328460A3/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
FR2626881B1 (fr) | 1990-07-27 |
CN1035290A (zh) | 1989-09-06 |
JPH01316369A (ja) | 1989-12-21 |
US4983599A (en) | 1991-01-08 |
DK52989D0 (da) | 1989-02-03 |
NO890519L (no) | 1989-08-11 |
DK52989A (da) | 1989-08-11 |
FR2626881A1 (fr) | 1989-08-11 |
EP0328460A3 (fr) | 1990-05-23 |
IL89186A0 (en) | 1989-09-10 |
NO890519D0 (no) | 1989-02-08 |
PT89666A (pt) | 1989-10-04 |
EP0328460A2 (fr) | 1989-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE101340T1 (de) | Neue arzneimittelformulierung sowie verfahren zu deren herstellung. | |
ATE230985T1 (de) | Verwendung von xanthophyllen zur herstellung von arzneimitteln zur verbesserung der muskel- funktionsdauer oder zur behandlung von muskelstörungen oder erkrankungen | |
DE69132688D1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
ATE17079T1 (de) | Praeparat zur behandlung von wunden der hautoberflaeche und verfahren zur herstellung des praeparats. | |
EG20001A (en) | Process for preparing of novel hydrox-amic acid and N-hydroxyurea derivatives and their use | |
DE3876877T2 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
FR2674524B1 (fr) | Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
ES2034035T3 (es) | Procedimiento de preparacion de una forma farmaceutica para la administracion y/o dosificacion de medicamentos. | |
KR930702000A (ko) | 노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용 | |
BE777689A (fr) | Nouveaux derives de l'imidazoline, compositions therapeutiques les contenant ainsi que le procede de preparation de ces derives et de ces compositions | |
BE875217A (fr) | Nouvelles oximes 0-substituees de l'acide 7-amino thiazolyl acetamido cephalosporanque, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant | |
DK461689D0 (da) | Anvendelse af aktive stoffer med seritoninagonistisk virkning til fremstilling af laegemidler med apoplexia cerebri | |
RU92016463A (ru) | Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе | |
ES451058A1 (es) | Un procedimiento de preparacion de un nuevo derivado de oxa-zol. | |
IL88971A (en) | Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them | |
FR2725988B1 (fr) | Nouveaux derives de pyrazolones et pyrazoles acides, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant | |
KR890012940A (ko) | 1-(4-아미노페닐)-2-헥사메틸렌이미노프로파논, 이의 제조방법 및 치료적 용도 | |
OA09121A (fr) | Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant. | |
KR890003373A (ko) | 수면장애 및 우울증 치료에 화합물의 이용 | |
HUT35958A (en) | Process for the production of pharmaceutical preparation suitable for therapic treatment of rheumatic diseases | |
ATE137237T1 (de) | R-(-)-1-(5-hydroxyhexyl)-3-methyl-7- propylxanthin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel | |
DE3261625D1 (en) | Tricyclic thiazolyl oxamic acids and derivatives, process for their production, and therapeutic agents containing them | |
IE870577L (en) | Topical amide preparation | |
ES2060440T3 (es) | Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos. | |
FR2340940A1 (fr) | Nouveaux benzamides, leur procede de preparation et leur application en tant que medicaments notamment destines au traitement d'etats depressifs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |